04:12 PM EST - Bradmer Pharmaceuticals Inc. : a clinical oncology company reported fourth quarter financial results, posting a loss that widened on higher expenses. Net loss for the quarter widened to US$ 3.517 million or US$ 0.26 per share from US$ 2.699 million or US$ 0.35 per share in the year ago quarter. Bradmer Pharmaceuticals Inc.
shares T.BMR are trading up 2 cents at $1.10.
